Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495995
What this trial is testing
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Cedars-Sinai Medical Center 94